CHAPTER
ONE

1.0:  INTRODUCTORY PERSPECTIVE

1.1:  BACKGROUND OF THE STUDY

1.2:  STATEMENT OF RESEARCH PROBLEM

1.3:  AIMS AND OBJECTIVES

1.4:  JUSTIFICATION OF THE STUDY

1.5:  SCOPE OF THE STUDY

1.6:  METHODOLOGY OF RESEARCH

1.7:  LITERATURE REVIEW

1.8: ORGANIZATIONAL
LAYOUT

CHAPTER
TWO

2.0: MEANING AND
NATURE OF CONSENT

2.1: MEANING OF
CONSENT

2.2: NATURE OF
CONSENT

2.3: TYPES OF
CONSENT

2.3.1: INFORMED
CONSENT

2.3.2: EXPRESS
CONSENT

2.3.3: IMPLIED
CONSENT

2.3.4:  CONSENT BY MINORS

2.3.5: PROXY OR
SURROGATE

CHAPTER
THREE

3.0: DOCTOR’S
DUTY OF DISCLOSURE IN CONSENT CASES

3.1: RISKS

3.2:
ALTERNATIVES

3.3: SIDE
EFFECTS AND CONSEQUENCES OF TREATMENT UNDERTAKEN

3.4: BENEFITS OF
TREATMENT UNDERTAKEN

CHAPTER
FOUR

4.0: CONSENT
UNDER THE NATIONAL HEALTH ACT, 2014.

4.1: HEALTH
STATUS OF THE PATIENT

4.2: DIAGNOSTIC
PROCEDURES

4.3: BENEFITS,
RISKS AND CONSEQUENCES OF THE TREATMENT UNDERTAKEN

4.4: IMPLICATION
OF REFUSING TREATMENT

4.5: VIOLATION
OF A PATIENT’S RIGHT TO CONSENT UNDER THE NATIONAL HEALTH ACT, 2014

CHAPTER
FIVE

5.0: CONCLUSION

5.1: FINDINGS

5.2: CONCLUSION

5.3:
RECOMMENDATIONS